A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9 - Wikidata - wikimedia - TriplyDB

A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9

A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9

http://www.wikidata.org/entity/Q36483327

about

Using CRISPR/Cas to study gene function and model disease in vivo Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcoma.Monocrotaline Induces Endothelial Injury and Pulmonary Hypertension by Targeting the Extracellular Calcium-Sensing Receptor.A CRISPR Path to Engineering New Genetic Mouse Models for Cardiovascular Research High throughput in vivo functional validation of candidate congenital heart disease genes in Drosophila.Transposase-mediated gene modulation in the placenta.Progress and Application of CRISPR/Cas Technology in Biological and Biomedical Investigation.Cardiac Regeneration: Lessons From Development.What rheumatologists need to know about CRISPR/Cas9.Animal Models of Congenital Cardiomyopathies Associated With Mutations in Z-Line Proteins.CRISPR-Cas9 technology: applications and human disease modelling.Applications of the CRISPR/Cas9 system in murine cancer modeling.Analysis of Cardiac Myocyte Maturation Using CASAAV, a Platform for Rapid Dissection of Cardiac Myocyte Gene Function In Vivo.In vivo and in vitro disease modeling with CRISPR/Cas9.Genome Editing of Monogenic Neuromuscular Diseases: A Systematic Review.Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research.Genome Editing for the Study of Cardiovascular Diseases.Promise of adeno-associated virus as a gene therapy vector for cardiovascular diseases.Targeted Genome Replacement via Homology-directed Repair in Non-dividing Cardiomyocytes.Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts.CASAAV: A CRISPR-Based Platform for Rapid Dissection of Gene Function In Vivo.Immunity to CRISPR Cas9 and Cas12a therapeutics.Genome Editing: The Recent History and Perspective in Cardiovascular Diseases.CASAAV Technology to Examine Regulators of Heart Failure: Cause or Effect.In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease.Noninheritable Maternal Factors Useful for Genetic Manipulation in Mammals.The Impact of CRISPR/Cas9 Technology on Cardiac Research: From Disease Modelling to Therapeutic Approaches.Considerations for Cardiac CRISPR.Optical Electrophysiology in the Developing Heart.Increased Frataxin Expression Induced in Friedreich Ataxia Cells by Platinum TALE-VP64s or Platinum TALE-SunTag.Delivering CRISPR: a review of the challenges and approaches CRISPR/Cas9 System: A Bacterial Tailor for Genomic Engineering Class 2 CRISPR/Cas: an expanding biotechnology toolbox for and beyond genome editing

P2860

Q28072587-09152BAC-755F-4C41-9084-ED1C4785BA14 Q33899910-58820D4D-0212-4AFA-B022-3F27DA746B8F Q36318985-F9B3369B-AB49-435D-B45B-FCF1F2AA281D Q36940626-BB3CE0DA-8DA4-4612-BFF3-AD7E139CAD41 Q37634284-447D10B9-E831-446B-8872-79C1AAAB4DAC Q38646672-2E557BAD-03CD-49F0-B36F-D1DDD459E1EB Q38700979-CCE3CE0A-3C25-4C21-A71A-E27F5D3FF773 Q38743894-EAD1668D-FDF6-4C9E-BD02-F0A5C00EA519 Q38756988-3E04DF22-3866-40E0-8121-5D40BDC15927 Q38832827-458272C7-2F27-4534-A523-6F959EABB42D Q38848400-1E8B7CFB-4628-43F5-A8C4-E5580F1598A6 Q38858314-AA32C214-4926-4A27-82C1-104E548F140B Q38868395-234AE1B5-A54D-424A-8739-C73CE78A16F2 Q38920337-F607218C-50D9-4781-995E-84ABD42BC5A1 Q38964549-4FF1CF83-85A1-48C5-80A0-EE2D6E66B529 Q38986995-4B2A384D-FCCE-4C6B-B07A-797596D8EE9C Q39144904-5D8B831D-CA5D-47E7-A734-172F81EB185E Q39356341-06DA8EF4-572A-41A4-AC14-AFC2CD1D129B Q40071090-7943FB82-8E03-4444-A935-B3CDF9BCAD99 Q40392730-F2810744-F8C8-4FB1-A5E7-AE56663810CB Q41926802-B08ED8B1-C01F-410E-AE30-A9DAE400DC7A Q45873745-B3999923-913B-4592-ABC4-97F13B5AAC6E Q45875285-0EEF4F26-6249-4845-ABC3-C1E5CF838458 Q46140075-889BEF6C-E6BA-430A-8660-9B1A2ADD3F62 Q47553772-7983F7CA-9CA0-4574-A1AE-6B41E90C7B1E Q47830954-0BC2ED20-8F0D-4CAC-B396-779B2821E37D Q49432567-BC349E01-A5A5-44E8-9595-69331394E3DC Q50091892-7927E890-C32B-4B00-8832-7CA553E47214 Q53822427-9420EBD3-0450-4AE9-ADD5-45F5BDF132CA Q55394024-2643CF0D-89EE-4FB9-AB56-A222D2B3FBC2 Q56610090-A0BF8C74-98BB-4497-97C8-CF1A795C73F3 Q57493121-CF7AF896-32CC-4BD2-AFCF-FC4B08B866C1 Q59127565-316A8F77-1C93-4A13-8C21-CF29C71BB343

P2860

A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9

http://www.wikidata.org/entity/Q36483327

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9

@ast

A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9

@en

type

label

A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9

@ast

A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9

@en

prefLabel

A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9

@ast

A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9

@en

P1433

Q36483327-167906E8-8FD2-491F-8D8D-7D6C20635A95

P1476

Q36483327-A37E2593-F15E-4BAC-BE7F-D771A965456D

P2093

Q36483327-03166F06-68B0-4059-B7CA-B046E59598B7

Q36483327-06ED6C89-4C4B-4852-92F7-8FCEAD582547

Q36483327-0A5A4103-367B-4201-8728-40F1E1C5C2C2

Q36483327-8505BE98-D13F-4A4E-A75B-08D94BADC329

Q36483327-9C8E198B-3732-42E4-A74A-9347D38D917E

Q36483327-B82B6D0F-B9FE-4E15-8AA5-07E8E939AFED

Q36483327-DD7A5397-4813-4CD2-9C34-F09B815DF13E

Q36483327-E098F16E-66E7-4588-A48F-7A698E645530

Q36483327-E0EC0F39-9125-4C4B-8B5D-28A621A04854

P2860

Q36483327-063FC2E3-8406-4255-8507-115BC92882DC

Q36483327-098EBC17-7B84-4EF3-A0A8-D7A485EF441E

Q36483327-0AD937E7-D85A-4891-9033-67054253B7F0

Q36483327-1103E367-76DA-4B2B-9B8A-09B57885BF07

Q36483327-14B28670-CD54-4427-9DC9-8209D7EECDC0

Q36483327-17FBD8D6-A69C-46DF-850F-D20FF7D7504E

Q36483327-19E4B06E-9C55-494F-8276-E53F9DA6D29E

Q36483327-1ACBAAE1-8FC2-4BE9-ACAE-185DF7DF85AD

Q36483327-290805BD-FA23-4D49-9C56-9FE067102FB6

Q36483327-2A364A0C-372F-4309-9EBA-0008FA87AEA7

P304

Q36483327-367EA288-D82E-4A4C-88F8-72D9E767B3DC

P31

Q36483327-B249298C-5666-452C-990C-7DFB3961C485

P356

Q36483327-743EA024-DE68-4694-8552-9BE712DDD188

P407

Q36483327-67A98010-299A-4048-8843-DE2A21B39BC8

P433

Q36483327-926E68C5-C0BD-4058-B40B-BB53B8D86554

P478

Q36483327-43916303-BBCC-48A7-81D7-9ED4570C651B

P577

Q36483327-A625EDB6-13EE-4509-A2C1-4C6E70941C1D

P698

Q36483327-DE1F2F93-82B9-4144-B07B-8D5C75FED7DE

P921

Q36483327-A2DFE723-B292-4796-9B0C-527B1D06FBB1

P932

Q36483327-51155A6A-D925-4555-B3B9-565002A45B6F

P356

PNAS.1523918113

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9

@en

P2093

Catherine A Makarewich

http://www.w3.org/2001/XMLSchema#string

Douglas M Anderson

http://www.w3.org/2001/XMLSchema#string

Eric N Olson

http://www.w3.org/2001/XMLSchema#string

John McAnally

http://www.w3.org/2001/XMLSchema#string

Kelli J Carroll

http://www.w3.org/2001/XMLSchema#string

Lorena Zentilin

http://www.w3.org/2001/XMLSchema#string

Mauro Giacca

http://www.w3.org/2001/XMLSchema#string

Ning Liu

http://www.w3.org/2001/XMLSchema#string

Rhonda Bassel-Duby

http://www.w3.org/2001/XMLSchema#string

P2860

CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes

Biotechnology. A prudent path forward for genomic engineering and germline gene modification

Genome engineering using the CRISPR-Cas9 system

Don’t edit the human germ line

Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy

Myosin heavy chain gene expression in human heart failure

RNA-guided human genome engineering via Cas9

Multiplex genome engineering using CRISPR/Cas systems

Efficient genome editing in zebrafish using a CRISPR-Cas system

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

P304

338-343

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1523918113

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26719419

http://www.w3.org/2001/XMLSchema#string

P921

P932

4720342

http://www.w3.org/2001/XMLSchema#string